|
Session 144
Poster Abstracts
Lipoatrophy and Mitochondrial Dysfunction
Tuesday, 1 - 4 pm
Poster Hall |
800
 |
The H63D Hemochromatosis (HFE) Gene Polymorphism and Mitochondrial Haplogroup J Are Associated with Limb Fat Changes after Initiation of ART: ACTG Study A5005s
Todd Hulgan*1, P Tebas2, J Canter1, K Mulligan3, D Haas1, M Dube4, S Grinspoon5, G Robbins5, A Kallianpur1, and ACTG Study 384 and A5005s Teams
1Vanderbilt Univ, Nashville, TN, US; 2Univ of Pennsylvania, Philadelphia, US; 3Univ of California, San Francisco, US; 4Indiana Univ Sch of Med, Indianapolis, US; and 5Massachusetts Gen Hosp, Harvard Univ, Boston, US |
801
|
Lipoatrophy and Ubiquitous mtDNA Depletion in Mice following Long-term Stavudine Treatment
Metodi Stankov*, R Schmidt, G Behrens, and German Competence Network HIV/AIDS
Hannover Med Sch, Germany |
802
|
Mitochondrial Toxicity in Adipose Tissue from HIV-infected Women during Pregnancy
Milena Nasi*1, E Chiesa2, G Rocco1, F Sabbatini1, A d’Arminio Monforte3, S Fiore4, E Ferrazzi4, N Palai5, C Campatelli6, and A Cossarizza1
1Univ of Modena and Reggio Emilia, Italy; 2Busto Arsizio Hosp, Varese, Italy; 3San Paolo Hosp, Milan, Italy; 4L Sacco Hosp, Milan, Italy; 5Univ of Brescia, Italy; and 6S Annunziata Hosp, Florence, Italy |
803
|
The Effects of Intermittent, CD4-guided ART on Peripheral Limb Fat and Metabolic Parameters: The SMART Body Composition Substudy
Fehmida Visnegarwala*1,2, Fehmida Visnegarwala*1,2, B Grund3, A Thomas3, K Ellis1, C Gibert4, J Shlay5, F Drummond6, E Martinez7, W El-Sadr8, A Carr9, and Body Composition Sub-study Investigators of the SMART trial
1Baylor Coll of Med, Houston, TX, US; 2CPCRA; 3Univ of Minnesota, Minneapolis, US; 4VAMC, Washington, DC, US; 5Denver CPCRA, Denver Publ Hlth, Univ of Colorado Hlth Sci Ctr, US; 6Natl Ctr for HIV Epidemiology and Clin Res, Univ of New South Wales, Australia; 7Hosp Clin, Univ of Barcelona, Spain; 8Harlem Hosp, Columbia Univ, New York, NY, US; and 9St Vincent's Hosp, Univ New South Wales, Sydney, Australia |
804
|
Body Composition Changes in ART-naive Subjects Treated with Atazanavir or Atazanavir/Ritonavir-based Once-daily HAART: 48-Week Computed Tomography and DEXA Data
Donnie McGrath*1, D Frederick1, V Wirtz1, R Yang1, A Thiry1, M Mathew1, and M Noor2
1Pharma Res Inst, Bristol-Myers Squibb, Wallingford, CT, US and 2Pharma Res Inst, Bristol-Myers Squibb, Princeton, NJ, US |
| 805 |
Improvements in Hepatic and Adipocyte Insulin Sensitivity, Dyslipidemia, and Visceral Fat during Leptin Treatment in HIV-infected Men with Lipoatrophy and Hypoleptinemia
Kathleen Mulligan*1, H Khatami1, J M Schwarz1,2, J M Schwarz1,2, G Sakkas1, A DePaoli3, G Lee1, V Tai1, M Wen1, C Grunfeld1, and M Schambelan1
1Univ of California, San Francisco, US; 2Touro Univ, Vallejo, CA, US; and 3Amgen, Inc, Thousand Oaks, CA, US |
806
|
International Case-control Study of Lactic Acidosis and Severe Hyperlactatemia in Treated HIV-infected Adults
Alejandro Arenas-Pinto and International Lactic Acidosis Study Group
Royal Free and Univ Coll London Med Sch, UK |
|
